So you need to start renal replacement therapy on your ICU patient?

Current Anaesthesia and Critical Care

Volumn 16, Issue 6, 2005, Pages 321-329

  Foot, Carole L ^a   Fraser, John F ^a  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

Dialysis; Haemodialysis; Kidney replacement therapy; Renal replacement therapy

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ACICLOVIR; ADENOSINE RECEPTOR BLOCKING AGENT; ALCOHOL; AMINOGLYCOSIDE; AMPHOTERICIN B; ANTICOAGULANT AGENT; BICARBONATE; CALCIUM; CONTRAST MEDIUM; DANAPAROID; DIURETIC AGENT; DOPAMINE; FENOLDOPAM; FUROSEMIDE; HEPARIN; HEPARINOID; LACTIC ACID; LEPIRUDIN; LITHIUM; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM; PROSTACYCLIN; RECOMBINANT HIRUDIN; SALICYLIC ACID DERIVATIVE; THEOPHYLLINE; UNINDEXED DRUG; VALPROIC ACID;

ACUTE KIDNEY FAILURE; ARTICLE; BIOFILTER; BLEEDING; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; DRUG DOSE REGIMEN; ELECTROLYTE DISTURBANCE; EXTRACORPOREAL CIRCULATION; HEMODIALYSIS; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HYPERKALEMIA; HYPOCALCEMIA; HYPOTENSION; INTENSIVE CARE UNIT; KIDNEY DISEASE; KIDNEY INJURY; METABOLIC ACIDOSIS; MORBIDITY; NEPHROTOXICITY; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; RENAL REPLACEMENT THERAPY; TREATMENT INDICATION; ULTRAFILTRATION; UREMIA; VASCULAR ACCESS; VASODILATATION;

EID: 33745714434     PISSN: 09537112     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cacc.2005.11.001     Document Type: Article

References (35)

1. O'Reilly P., and Tolwani A. Renal replacement therapy III: IHD, CRRT, SLED. Crit Care Clin 21 (2005) 367-378
2. Feest T.G., Rajamahesh J., Byrne C., et al. Trends in adult renal replacement therapy in the UK: 1982-2002. Q J Med 98 (2005) 21-28
3. Bellomo R., and Ronco C. Acute renal replacement therapy: haemofiltration or haemodiafiltration or haemodialysis. Int J Intensive Care Med 12 (2005) 30-37
4. Lameire N., VanBlesen W., and Vanholder R. Acute renal failure. Lancet 365 (2005) 417-430
5. Palevsky P.M. Renal replacement therapy I: indications and timing. Crit Care Clin 21 (2005) 347-356
6. Hussain S.A., and Cheng E.Y. Causes and prevention of acute renal failure in the critically ill patient. Contemporary Crit Care 2 10 (2005) 1-10
7. Bellomo R., Chapman M., Finfer S., et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Lancet 356 (2000) 2139-2143
8. Mehta R.L., and Chertow G.M. Diuretics in critically ill patients with acute renal failure. JAMA 289 (2003) 1379-1381
9. Weisbord S.D., and Palevsky P.M. Radiocontrast-induced acute renal failure. J Intensive Care Med 20 (2005) 63-75
10. Birck R., Krzossok S., Markowetz F., et al. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 362 (2003) 598-603
11. Merten G.J., Burgess W.P., Gray L.V., et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291 (2004) 2328-2334
12. Madyoon H. Clinical experience with the use of fenoldopam for prevention of radiocontrast nephropathy in high-risk patients. Rev Cardiovasc Med 2 Suppl 1 (2001) S26-S30
13. Lin J., and Bonventre J.V. Prevention of radiocontrast nephropathy. Curr Opin Nephrol Hypertens 14 (2005) 105-110
14. Vogt B., Ferrari P., Schonholzer C., et al. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 111 (2001) 692-698
15. Marenzi G., Marana I., Lauri G., et al. The prevention of radiocontrast-agent-indced nephropathy by hemofiltration. N Engl J Med 349 (2003) 1333-1340
16. Kellum J.A., Angus D.C., Johnson J.P., et al. Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med 28 (2002) 29-37
17. Eknoyan G., Beck G.J., Cheung A.K., et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347 (2002) 2010-2019
18. Ronco C., Bellomo R., Homel P., et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomsed trial. Lancet 356 (2000) 26-30
19. Ronco C. Haemodialysis filters: what's new?. Curr Opin Nephrol Hypertens 8 (1999) 709-713
20. Alonso A., Lau J., and Jaber B.L. Biocompatible hemodialysis membranes for acute renal failure. Cochrane Library 2 (2005) 1-42
21. Abramson S., and Niles J.L. Anticoagulation in continuous renal replacement therapy. Curr Opin Nephrol Hypertens 8 (1999) 701-707
22. Morabito S., Guzzo I., Solazzo A., Muzi L., Luciani R., and Pierucci A. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding. J Nephrol 16 (2003) 566-571
23. Kutsogiannis D.J., Ibney R.T., Stollery D., and Gao J. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patents. Kidney Int 67 (2005) 2361-2367
24. Farner B., Eichler P., Kroll H., and Greinacher A. A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia. Thromb Haemost 85 (2001) 950-957
25. Matsuo T., Kario K., Nakao, Yamada T., and Matsuo M. Anticoagulation with nafamostat mesilate, a synthetic protease inhibitor, in hemodialysis patients with a bleeding risk. Haemostasis 23 (1993) 135-141
26. Leblanc M., Fedak S., Mokris G., and Paganini E.P. Blood recirculation in temporary central catheters for acute hemodialysis. Clin Nephrol 45 (1996) 315-319
27. Oguzkurt L., Terean F., Torun D., Yildirim T., Zumrutdl A., and Kizilkilic O. Impact of short-term hemodialysis catheters on the central veins: a catheter venographic study. Eur J Radiol 52 (2004) 293-299
28. Schillinger F., Schillinger D., Montagna R., and Milcent T. Post catheterisation vein stenosis in hemodialysis: comparative angiographic study of 50 subclavian and 50 internal jugular accesses. Nephron Dial Transplant 6 (1991) 722-724
29. Heering P., Ivens K., Thumer O., et al. The use of different buffers during continuous hemofiltration in critically ill patients with acute renal failure. Intensive Care Med 25 (1999) 1244-1251
30. Cole L., Bellomo R., Baldwin I., Hayhoe M., and Ronco C. The impact of lactate-buffered high-volume hemofiltration on acid-base balance. Intensive Care Med 29 (2003) 1113-1120
31. Barenbrock M., Hausberg M., Matzkies F., de la Motte S., and Schaefer R.M. Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients. Kidney Int 58 4 (2000) 1751-1757
32. Maxvold N.J., and Bunchma T.E. Renal failure and renal replacement therapy. Crit Care Clin 19 (2003) 563-575
33. Phu N.H., Hien T.T., Mai N.T.H., et al. Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med 347 (2002) 895-902
34. Lindsay R.M., Leitch R., Heidenheim A.P., and Kortas C. London Daily/Nocturnal Hemodialysis Study. The London Daily/Nocturnal Hemodialysis Study-study design, morbidity, and mortality results. Am J Kidney Dis 42 Suppl 1 (2003) 5-12
35. Hassell K. The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy. Chest 127 2 (2005) 1S-8S